Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B07b21355ce2df2a406a2431b69dfb0f2> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B07b21355ce2df2a406a2431b69dfb0f2 NCIT_P378 "NCI" @default.
- B07b21355ce2df2a406a2431b69dfb0f2 type Axiom @default.
- B07b21355ce2df2a406a2431b69dfb0f2 annotatedProperty IAO_0000115 @default.
- B07b21355ce2df2a406a2431b69dfb0f2 annotatedSource NCIT_C103297 @default.
- B07b21355ce2df2a406a2431b69dfb0f2 annotatedTarget "A synthetic, multivalent, lysine-rich, pseudopeptide and nucleolin antagonist with potential anti-angiogenic, antineoplastic and pro-apoptotic activities. Upon administration, IPP-204106N antagonizes nucleolin leading to a downregulation of cell-surface nucleolin; preventing the binding of certain growth promoting ligands to nucleolin may suppress tumor cell proliferation and angiogenesis. In addition, IPP-204106N is able to translocate to the nucleolus and bind to nucleolar nucleolin. This prevents nucleolin from binding to and stabilizing mRNA of the anti-apoptotic Bcl2; destabilizing Bcl2 mRNA leads to a reduction in Bcl2 protein synthesis and induces apoptosis. Further, this agent can antagonize nucleophosmin. Nucleolin, a nucleolar phosphoprotein, is overexpressed on the cell surface of certain cancer cells and binds ligands involved in cell proliferation, adhesion and angiogenesis." @default.